Shell Asset Management CO Ironwood Pharmaceuticals Inc Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Shell Asset Management CO holds 27,809 shares of IRWD stock, worth $98,165. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,809

Previous 28,496 2.41%

Holding current value

$98,165

Previous $186,000 38.17%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$3.93 - $7.04 $2,699 - $4,836	-687 Reduced 2.41%	27,809 $115,000
Q1 2024 Jul 31, 2024	SELL	$8.32 - $15.45 $14,951 - $27,763	-1,797 Reduced 5.93%	28,496 $186,000
Q1 2024 May 14, 2024	SELL	$8.32 - $15.45 $8,810 - $16,361	-1,059 Reduced 3.38%	30,293 $264,000
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $83,311 - $109,091	-9,478 Reduced 23.21%	31,352 $359,000
Q3 2023 Nov 08, 2023	SELL	$8.25 - $11.35 $5,222 - $7,184	-633 Reduced 1.53%	40,830 $393,000
Q2 2023 Jul 28, 2023	SELL	$10.1 - $11.6 $2,363 - $2,714	-234 Reduced 0.56%	41,463 $441,000
Q1 2023 May 15, 2023	SELL	$10.37 - $12.56 $1,493 - $1,808	-144 Reduced 0.34%	41,697 $439,000
Q4 2022 Feb 07, 2023	SELL	$9.9 - $12.43 $87,496 - $109,856	-8,838 Reduced 17.44%	41,841 $518,000
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $134,659 - $164,406	-13,280 Reduced 20.76%	50,679 $525,000
Q2 2022 Aug 09, 2022	BUY	$11.05 - $12.72 $1,204 - $1,386	109 Added 0.17%	63,959 $737,000
Q1 2022 May 04, 2022	SELL	$10.61 - $12.88 $100,211 - $121,651	-9,445 Reduced 12.89%	63,850 $803,000
Q4 2021 Feb 09, 2022	BUY	$10.86 - $13.95 $3,670 - $4,715	338 Added 0.46%	73,295 $855,000
Q3 2021 Nov 04, 2021	SELL	$11.92 - $13.92 $37,309 - $43,569	-3,130 Reduced 4.11%	72,957 $953,000
Q2 2021 Aug 12, 2021	BUY	$10.16 - $13.11 $218,927 - $282,494	21,548 Added 39.51%	76,087 $979,000
Q1 2021 May 10, 2021	BUY	$9.04 - $11.86 $290,292 - $380,848	32,112 Added 143.18%	54,539 $610,000
Q2 2020 Aug 10, 2020	BUY	$9.14 - $11.97 $101,974 - $133,549	11,157 Added 99.0%	22,427 $231,000
Q1 2020 May 11, 2020	SELL	$8.58 - $14.01 $1,475 - $2,409	-172 Reduced 1.5%	11,270 $114,000
Q4 2019 Feb 13, 2020	SELL	$8.22 - $14.0 $2,309 - $3,934	-281 Reduced 2.4%	11,442 $152,000
Q3 2019 Nov 12, 2019	SELL	$8.59 - $10.96 $867 - $1,106	-101 Reduced 0.85%	11,723 $101,000
Q2 2019 Aug 12, 2019	SELL	$9.8 - $12.89 $2,646 - $3,480	-270 Reduced 2.23%	11,824 $129,000
Q4 2018 Feb 13, 2019	SELL	$7.8 - $16.13 $7,800 - $16,129	-1,000 Reduced 7.64%	12,094 $125,000
Q2 2018 Aug 10, 2018	SELL	$11.83 - $16.2 $8,742 - $11,971	-739 Reduced 5.34%	13,094 $250,000
Q4 2017 Feb 09, 2018	BUY	$12.16 - $14.58 $168,209 - $201,685	13,833	13,833 $207,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Ironwood Pharmaceuticals Inc Transaction History